Over the last 7 days, the United States market has experienced a slight decline of 1.1%, yet it remains up by 9.1% over the past year with earnings forecasted to grow by 14% annually. In this environment, identifying stocks that may be priced below their fair value estimates can offer potential opportunities for investors looking to capitalize on future growth prospects.
Top 10 Undervalued Stocks Based On Cash Flows In The United States
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Berkshire Hills Bancorp (NYSE:BHLB) | $25.28 | $50.03 | 49.5% |
| Super Group (SGHC) (NYSE:SGHC) | $8.34 | $16.48 | 49.4% |
| UMH Properties (NYSE:UMH) | $16.46 | $32.43 | 49.2% |
| Horizon Bancorp (NasdaqGS:HBNC) | $15.09 | $29.88 | 49.5% |
| Insteel Industries (NYSE:IIIN) | $35.96 | $71.77 | 49.9% |
| Carvana (NYSE:CVNA) | $292.09 | $580.88 | 49.7% |
| TXO Partners (NYSE:TXO) | $15.25 | $29.92 | 49% |
| Array Technologies (NasdaqGM:ARRY) | $7.11 | $14.09 | 49.5% |
| MAC Copper (NYSE:MTAL) | $10.08 | $20.05 | 49.7% |
| Clearfield (NasdaqGM:CLFD) | $37.81 | $74.47 | 49.2% |
Let's take a closer look at a couple of our picks from the screened companies.
STAAR Surgical (NasdaqGM:STAA)
Overview: STAAR Surgical Company, along with its subsidiaries, specializes in designing, developing, manufacturing, and selling implantable lenses for the eye and accessory delivery systems, with a market cap of approximately $952.57 million.
Operations: The company's revenue primarily comes from its ophthalmic surgical products, totaling $279.13 million.
Estimated Discount To Fair Value: 22.5%
STAAR Surgical is trading at US$18.45, significantly below its estimated fair value of US$23.82, suggesting potential undervaluation based on cash flows. The company anticipates becoming profitable within three years, with revenue projected to grow 10.1% annually, outpacing the broader US market growth rate of 8.5%. Despite a challenging first quarter with a net loss of US$54.21 million, STAAR's recent $30 million share repurchase program underscores confidence in future cash flow generation.
- Upon reviewing our latest growth report, STAAR Surgical's projected financial performance appears quite optimistic.
- Take a closer look at STAAR Surgical's balance sheet health here in our report.
Turning Point Brands (NYSE:TPB)
Overview: Turning Point Brands, Inc. manufactures, markets, and distributes branded consumer products in the United States and Canada with a market cap of $1.31 billion.
Operations: The company's revenue is primarily derived from its Zig-Zag Products, generating $192.96 million, and Stoker’s Products, contributing $191.07 million.
Estimated Discount To Fair Value: 19.7%
Turning Point Brands, trading at US$73.1, is below its estimated fair value of US$91.01, indicating potential undervaluation based on cash flows. With revenue forecasted to grow 22.2% annually, outpacing the US market's 8.5%, and earnings expected to increase by 15.2% per year, the company shows strong growth prospects despite significant insider selling recently and a high debt level. Recent Q1 results reported sales of US$106.44 million and net income of US$14.4 million.
- In light of our recent growth report, it seems possible that Turning Point Brands' financial performance will exceed current levels.
- Delve into the full analysis health report here for a deeper understanding of Turning Point Brands.
ZEEKR Intelligent Technology Holding (NYSE:ZK)
Overview: ZEEKR Intelligent Technology Holding Limited is an investment holding company involved in the research, development, production, commercialization, and sale of electric vehicles and batteries, with a market cap of approximately $7.25 billion.
Operations: ZEEKR Intelligent Technology Holding Limited generates revenue primarily through the research, production, commercialization, and sale of electric vehicles and batteries.
Estimated Discount To Fair Value: 48.9%
ZEEKR Intelligent Technology Holding is trading at CNY 29.61, significantly below its estimated fair value of CNY 57.94, suggesting it could be undervalued based on cash flows. Despite current net losses, the company reported improved Q1 results with reduced losses and increased sales to CNY 19.10 billion from last year. Revenue is projected to grow at 23.9% annually, surpassing the US market's growth rate, while profitability is anticipated within three years despite ongoing acquisition evaluations by Geely Automobile Holdings Limited for a complete stake purchase valued at $2.3 billion.
- Our earnings growth report unveils the potential for significant increases in ZEEKR Intelligent Technology Holding's future results.
- Get an in-depth perspective on ZEEKR Intelligent Technology Holding's balance sheet by reading our health report here.
Where To Now?
- Click through to start exploring the rest of the 166 Undervalued US Stocks Based On Cash Flows now.
- Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
- Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.
Looking For Alternative Opportunities?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if ZEEKR Intelligent Technology Holding might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com